KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Share-based Compensation: 2019-2024

Historic Share-based Compensation for Hims & Hers Health (HIMS) over the last 6 years, with Dec 2024 value amounting to $92.3 million.

  • Hims & Hers Health's Share-based Compensation rose 61.34% to $40.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $125.1 million, marking a year-over-year increase of 45.87%. This contributed to the annual value of $92.3 million for FY2024, which is 39.71% up from last year.
  • Per Hims & Hers Health's latest filing, its Share-based Compensation stood at $92.3 million for FY2024, which was up 39.71% from $66.1 million recorded in FY2023.
  • Over the past 5 years, Hims & Hers Health's Share-based Compensation peaked at $92.3 million during FY2024, and registered a low of $5.8 million during FY2020.
  • For the 3-year period, Hims & Hers Health's Share-based Compensation averaged around $67.1 million, with its median value being $66.1 million (2023).
  • In the last 5 years, Hims & Hers Health's Share-based Compensation soared by 1,052.65% in 2021 and then crashed by 36.29% in 2022.
  • Hims & Hers Health's Share-based Compensation (Yearly) stood at $5.8 million in 2020, then soared by 1,052.65% to $67.2 million in 2021, then slumped by 36.29% to $42.8 million in 2022, then spiked by 54.33% to $66.1 million in 2023, then spiked by 39.71% to $92.3 million in 2024.